微血管减压术治疗55例面肌痉挛的疗效与并发症
该回顾性研究纳入55例接受乙状窦后微血管减压术的面肌痉挛患者,平均随访7.4年,总体治愈率83.64%,复发率9.8%,永久性面瘫3.63%、单侧耳聋5.45%、听力下降3.63%,无死亡,94.7%患者术后HFS-8评分为0。结论认为该术式有效持久、并发症少且生活质量改善显著。
要点
- 总体治愈率83.64%,平均随访7.4年,复发率9.8%。
- 永久性面瘫3.63%、单侧耳聋5.45%、听力下降3.63%,无死亡。
- 94.7%患者术后HFS-8生活质量评分为0。
核心结论
- 微血管减压术治疗面肌痉挛有效且持久,并发症发生率低,生活质量改善显著。
研究设计与样本
- 回顾性研究,纳入2004年5月至2017年1月接受乙状窦后微血管减压术的55例面肌痉挛患者,排除术前MRI无血管冲突或另有诊断者。
主要发现
- 总体治愈率83.64%,平均随访7.4年;中远期疗效3年88%、5年90.24%、8年90.48%;复发率9.8%。
- 左侧面肌痉挛为愈合促进因素(P = .01);右侧痉挛(P = .01)和平均年龄62岁(P = .03)为有利标准。
- 特异性并发症包括永久性面瘫3.63%、单侧耳聋5.45%、听力下降3.63%,无死亡报告。
- 94.7%患者术后改良HFS-8生活质量评分为0。
关键数值与推荐
- 愈合中位时间0.03个月,平均6个月。
- 总体治愈率83.64%,复发率9.8%,随访3年疗效88%、5年90.24%、8年90.48%。
- 永久性面瘫3.63%,单侧耳聋5.45%,听力下降3.63%。
- 术后HFS-8评分为0者占94.7%。
临床怎么用
- 当肉毒素注射无效或耐受性差时,应尽早向患者推荐微血管减压术。
局限性
- 回顾性研究,单中心区域医院,样本量55例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To analyze the efficacy and complications of microvascular decompression for hemifacial spasm. STUDY DESIGN: Retrospective study. SETTING: Regional hospital. METHODS: Fifty-five patients with hemifacial spasm were treated by microvascular decompression. All patients with hemifacial spasm who underwent retrosigmoid microvascular decompression from May 2004 to January 2017 were included. Patients with no conflict on preoperative magnetic resonance imaging or with an alternate diagnosis were excluded. RESULTS: The overall cure rate was 83.64%, with an average follow-up of 7.4 years. A left-sided hemifacial spasm was a healing-promoting factor (P = .01). The median healing was 0.03 months, and the mean was 6 months. The efficacy remained high in the medium term (88% at 3 years), long term (90.24% at 5 years), and very long term (90.48% at 8 years). The recurrence rate was 9.8%. Favorable criteria included a right-sided spasm (P = .01) and an average age of 62 years (P = .03). The specific complications were permanent facial palsy (3.63%), unilateral deafness (5.45%), and hearing loss (3.63%). No death was reported. Regarding the quality of life of the patients, 94.7% had a modified HFS-8 postoperative score of 0 (Hemifacial Spasm 8 Quality of Life Scale). CONCLUSION: Microvascular decompression for hemifacial spasm is an effective and lasting technique. Its low rate of complications and the considerable quality-of-life improvement should lead surgeons to propose it to patients as soon as botulinum toxin injections become ineffective or poorly tolerated.
引用
- Compagnon C, Labrousse M, Brenet E, et al. Efficacy and Complications of Microsurgical Neurovascular Decompression in 55 Patients With Hemifacial Spasm. Otolaryngol Head Neck Surg. 2020. PMID: 33198570. doi:10.1177/0194599820969168
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。